APOE ɛ4 exacerbates age-dependent deficits in cortical microstructure
- PMID: 38384997
- PMCID: PMC10881196
- DOI: 10.1093/braincomms/fcad351
APOE ɛ4 exacerbates age-dependent deficits in cortical microstructure
Abstract
The apolipoprotein E ɛ4 allele is the primary genetic risk factor for the sporadic type of Alzheimer's disease. However, the mechanisms by which apolipoprotein E ɛ4 are associated with neurodegeneration are still poorly understood. We applied the Neurite Orientation Dispersion Model to characterize the effects of apolipoprotein ɛ4 and its interactions with age and education on cortical microstructure in cognitively normal individuals. Data from 1954 participants were included from the PREVENT-Dementia and ALFA (ALzheimer and FAmilies) studies (mean age = 57, 1197 non-carriers and 757 apolipoprotein E ɛ4 carriers). Structural MRI datasets were processed with FreeSurfer v7.2. The Microstructure Diffusion Toolbox was used to derive Orientation Dispersion Index maps from diffusion MRI datasets. Primary analyses were focused on (i) the main effects of apolipoprotein E ɛ4, and (ii) the interactions of apolipoprotein E ɛ4 with age and education on lobar and vertex-wise Orientation Dispersion Index and implemented using Permutation Analysis of Linear Models. There were apolipoprotein E ɛ4 × age interactions in the temporo-parietal and frontal lobes, indicating steeper age-dependent Orientation Dispersion Index changes in apolipoprotein E ɛ4 carriers. Steeper age-related Orientation Dispersion Index declines were observed among apolipoprotein E ɛ4 carriers with lower years of education. We demonstrated that apolipoprotein E ɛ4 worsened age-related Orientation Dispersion Index decreases in brain regions typically associated with atrophy patterns of Alzheimer's disease. This finding also suggests that apolipoprotein E ɛ4 may hasten the onset age of dementia by accelerating age-dependent reductions in cortical Orientation Dispersion Index.
Keywords: NODDI; cognitive impairment; neurodegeneration; preclinical dementia.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.
Conflict of interest statement
Unrelated to this work, J.T.O.B. has received honoraria for work as DSMB chair or member for TauRx, Axon, Eisai, has acted as a consultant for Roche, and has received research support from Alliance Medical and Merck.
Figures
References
-
- Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261(5123):921–923. - PubMed
-
- Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer’s disease. Annu Rev Neurosci. 1996;19:53–77. - PubMed
-
- Habib M, Mak E, Gabel S, et al. Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer’s disease. Ageing Res Rev. 2017;36:88–104. - PubMed
-
- Mak E, Gabel S, Mirette H, et al. Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes. Ageing Res Rev. 2017;35:250–264. - PubMed
-
- Dounavi ME, Mak E, Wells K, et al. Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia. Neurobiol Aging. 2020;91:36–44. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous